CDKN2B-AS1 and cancer: CDKN2B-AS, also known as ANRIL, is a lncRNA transcribed in the antisense direction of CDKN2A and CDKN2B. ANRIL is a well-established tumor suppressor whose function is disabled in human cancers [45].